Quest Diagnostics (DGX) Stock: Buy, Sell, or Hold?
DGX - Quest Diagnostics Inc.
$247.67
5.11 (2.11%)
▲
5d:
+3.66%
30d:
+6.77%
90d:
+5.71%
WAIT
LOW Confidence
Analysis Updated: Oct 27, 2026 12:00 AM ET
Earnings: Oct 22, 2026
0d
Get Alerted When DGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: DGX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: DGX shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$277.40
Based on 5.1% avg growth
INTRINSIC VALUE TODAY
$172.24
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DGX is currently trading at $247.67, which is considered extended relative to its 30-day fair value range of $230.55 to $242.07. From a valuation perspective, the stock is trading at a premium (Forward PE: 20.2) compared to its historical average (18.1). At these levels, the market is pricing in 3.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DGX is in a strong uptrend. The price is approaching resistance at $246.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DGX scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DGX is in a strong uptrend. The price is approaching resistance at $246.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DGX scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$230.55 -
$242.07
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
24.8%
Protect Your Profits
Holding DGX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($254.73)
- NEUTRAL: Market pricing in 3.9% annual earnings growth - fairly valued
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$230.55 -
$242.07
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$223.50
Resistance Level
$246.00
Current Trend
Strong Uptrend
Technical data as of
Oct 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.24
Wall Street Target
$254.73
(+5.0%)
Revenue Growth (YoY)
10.0%
Earnings Growth (YoY)
28.7%
Profit Margin
9.5%
Valuation Premium vs History
+3.9% premium
PE vs Historical
20.2 vs 18.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.9%
(market-implied from PE analysis)
1-Year Target
$252.02
(+4%)
2-Year Target
$261.85
(+8%)
3-Year Target
$272.06
(+12%)
3-Yr Target (if PE normalizes)
(PE: 20→18)
PE COMPRESSION
$243.24
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 6.1%)
$289.97
(+20%)
Base:
(SPY PE: 19.9, Growth: 6.1%)
$284.46
(+17%)
Bear:
(PE: 16.9, Growth: 6.1%)
$241.79
(0%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 24.20 | Current EPS (TTM): $10.04
Bull Case
$318.92
(+32%)
Analyst growth 19.3%, PE expands to 26.6
Base Case
$289.93
(+20%)
Market implied 19.3%, PE stable at 24.2
Bear Case
$165.21
(-32%)
Severe decline -20.0%, PE contracts to 20.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 28, 2026 10:17 AM ET
Data refreshes hourly during market hours. Next update: 11:17 AM
Data refreshes hourly during market hours. Next update: 11:17 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 50 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$751 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$411 | 60 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$259 | 42 HOLD |
Advanced DGX Option Strategies
Professional options setups generated by AI based on today's DGX price and gamma walls.
